Finance

Lists
PHARMA:KLSE
Pharmaniaga Bhd
MYR 0.76
-1.29%
(-0.0100) 1D
Nov 16, 5:00:00 PM GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for PHARMA...
Open
MYR 0.77
High
MYR 0.80
Low
MYR 0.76
Mkt. cap
996.79M
Avg. vol.
2.03M
Volume
1.72M
Dividend
2.68%
Quarterly dividend
MYR 0.01
Ex-dividend date
Sep 14, 2026
P/E ratio
12.88
52-wk high
MYR 1.70
52-wk low
MYR 0.72
EPS
MYR 0.06
Shares outstanding
1.31B
No. of employees
4K
Open
MYR 0.77
High
MYR 0.80
Low
MYR 0.76
Mkt. cap
996.79M
Avg. vol.
2.03M
Volume
1.72M
Dividend
2.68%
Quarterly dividend
MYR 0.01
Ex-dividend date
Sep 14, 2026
P/E ratio
12.88
52-wk high
MYR 1.70
52-wk low
MYR 0.72
EPS
MYR 0.06
Shares outstanding
1.31B
No. of employees
4K
News stories
From web sources and news partners
Profile
Pharmaniaga Berhad is Malaysia’s largest listed integrated healthcare company, offering research and development, manufacturing, logistics, and distribution of pharmaceuticals and medical supplies. Wikipedia
About Pharmaniaga Bhd
CEOZulkarnain Md Eusope
Employees3.5K
Founded1994
Headquarters-
SectorHealth Care
IndustryHealth care provider
Previous reportsAll values in MYR
Loading Previous Earnings...
Revenue
Net income
All values in MYR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
938.28M
1.18B
1.04B
1.01B
Cost of goods sold
841.28M
1.05B
939.04M
915.63M
Cost of revenue
841.28M
1.05B
939.04M
915.63M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48.05M
73.51M
75.89M
75.39M
Operating expense
73.67M
73.51M
75.89M
75.39M
Total operating expenses
914.96M
1.12B
1.01B
991.02M
Operating income
23.32M
55.02M
26.10M
23.45M
Other non operating income
-2.18M
92.00K
107.00K
89.00K
EBT including unusual items
11.44M
46.41M
17.81M
13.03M
EBT excluding unusual items
11.18M
46.41M
17.81M
13.03M
Income tax expense
2.71M
14.22M
4.78M
-13.91M
Effective tax rate
23.69%
30.64%
26.87%
-106.78%
Other operating expenses
-
-
-
-
Net income
7.70M
31.47M
12.49M
26.27M
Net profit margin
0.82%
2.67%
1.20%
2.59%
Earnings per share
-
-
-
-
Interest and investment income
2.20M
1.38M
1.79M
947.00K
Interest expense
-12.17M
-10.08M
-10.19M
-11.46M
Net interest expenses
-9.96M
-8.70M
-8.40M
-10.51M
Depreciation and amortization charges
19.12M
-
-
-
EBITDA
30.81M
64.67M
32.51M
29.86M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps